关联交易
Search documents
镇洋发展: 浙江镇洋发展股份有限公司第二届监事会第十六次会议决议公告
Zheng Quan Zhi Xing· 2025-09-02 17:11
证券代码:603213 证券简称:镇洋发展 公告编号:2025-045 转债代码:113681 转债简称:镇洋转债 浙江沪杭甬高速公路股份有限公司(以下简称"浙江沪杭甬" )、镇 浙江镇洋发展股份有限公司 第二届监事会第十六次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和 完整性承担法律责任。 一、监事会会议召开情况 浙江镇洋发展股份有限公司(以下简称"公司"或"镇洋发展" )第二届监事会第十六次会议于2025年9月2日在浙江省宁波市镇海 区宁波石化经济技术开发区海天中路655号712会议室以现场方式召开。 会议通知已于2025年8月27日以书面形式送达。本次会议应出席监事 议的召集、召开和表决程序均符合《公司法》《公司章程》及相关 法律法规的规定。 二、监事会会议审议情况 本次会议对以下议案进行逐项审议并表决,形成如下决议: (一)审议通过《关于本次交易符合上市公司重大资产重组相关 法律法规规定的议案》 洋发展经协商,拟由浙江沪杭甬向公司全体股东发行 A 股股份换股吸 收合并镇洋发展(以下简称"本次交易" )。根据《上市公司重大资 ...
镇洋发展: 浙江镇洋发展股份有限公司第二届董事会第二十七次会议决议公告
Zheng Quan Zhi Xing· 2025-09-02 17:11
证券代码:603213 证券简称:镇洋发展 公告编号:2025-044 转债代码:113681 转债简称:镇洋转债 浙江镇洋发展股份有限公司 第二届董事会第二十七次会议决议公告 公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和 完整性承担法律责任。 一、董事会会议召开情况 浙江镇洋发展股份有限公司(以下简称"公司"或"镇洋发展" )第二 届董事会第二十七次会议于 2025 年 9 月 2 日在浙江省宁波市镇海区宁波石 化经济技术开发区海天中路 655 号 712 会议室以现场结合通讯方式召开。 会议通知已于 2025 年 8 月 27 日以书面形式送达。本次会议应出席董事 9 名,实际出席董事 9 名。会议由董事长沈曙光先生主持,监事、高级管理 人员列席。本次会议的召集、召开和表决程序均符合《公司法》 《公司章程》 及相关法律法规的规定。 二、董事会会议审议情况 本次会议对以下议案进行逐项审议并表决,形成如下决议: (一)审议通过《关于本次交易符合上市公司重大资产重组相关法律 法规规定的议案》 浙江沪杭甬高速公路股份有限公司(以下简称"浙江沪杭甬" ...
镇洋发展: 浙江沪杭甬高速公路股份有限公司换股吸收合并浙江镇洋发展股份有限公司暨关联交易预案(摘要)
Zheng Quan Zhi Xing· 2025-09-02 17:11
Core Viewpoint - Zhejiang Hu-Hang-Yong Highway Co., Ltd. plans to absorb and merge with Zhejiang Zhenyang Development Co., Ltd. through a share exchange, with the aim of enhancing its business scope and operational efficiency [9][21]. Group 1: Transaction Overview - The transaction involves Zhejiang Hu-Hang-Yong issuing A-shares to exchange for all shares held by Zhenyang Development, leading to Zhenyang's delisting and eventual dissolution [9][21]. - The exchange ratio is set at 1:1.0800, meaning each share of Zhenyang will convert into 1.0800 shares of Zhejiang Hu-Hang-Yong [11][12]. - The A-share issuance price for Zhejiang Hu-Hang-Yong is determined at RMB 13.50 per share, with a premium of 29.83% over Zhenyang's average share price of RMB 11.23 [10][11]. Group 2: Financial Implications - Following the merger, Zhejiang Hu-Hang-Yong will inherit all assets, liabilities, and operations of Zhenyang, thereby expanding its business into the chemical sector [26][27]. - The total number of A-shares to be issued for the merger is approximately 477,246,833 shares, based on Zhenyang's total share capital of 441,895,215 shares [12][21]. - The merger is expected to optimize the governance structure and enhance resource allocation efficiency, thereby strengthening the company's competitive position [27]. Group 3: Shareholder Rights and Obligations - Shareholders of both companies who oppose the merger will have the right to request cash compensation for their shares, with the cash offer being provided by the controlling shareholder, Traffic Group [15][19]. - The merger will not change the actual controller of Zhejiang Hu-Hang-Yong, which remains Traffic Group, ensuring continuity in management and strategic direction [25][26]. - The cash dividend policy post-merger will ensure a minimum annual cash distribution of RMB 0.4100 per share for the next three years, subject to legal and regulatory compliance [25].
镇洋发展: 浙江沪杭甬高速公路股份有限公司换股吸收合并浙江镇洋发展股份有限公司暨关联交易预案
Zheng Quan Zhi Xing· 2025-09-02 17:11
Overview of the Merger - The merger involves Zhejiang Huhangyong Expressway Co., Ltd. absorbing Zhejiang Zhanyang Development Co., Ltd. through a share exchange, with Zhejiang Huhangyong as the absorbing party and Zhejiang Zhanyang as the absorbed party [10][23] - After the merger, Zhejiang Zhanyang will terminate its listing and eventually deregister as a legal entity, while Zhejiang Huhangyong will inherit all assets, liabilities, and rights of Zhejiang Zhanyang [10][23] Share Exchange Details - The share exchange ratio is set at 1:1.0800, meaning each share of Zhejiang Zhanyang will be exchanged for 1.0800 shares of Zhejiang Huhangyong [12][13] - The issuance price for Zhejiang Huhangyong's A shares is set at RMB 13.50 per share, with a premium of 29.83% over the average price of Zhejiang Zhanyang's shares [11][12] Financial Implications - As of the signing of the proposal, Zhejiang Zhanyang has a total share capital of 441,895,215 shares, leading to the issuance of approximately 477,246,833 shares of Zhejiang Huhangyong for the merger [13] - The merger is classified as a major asset restructuring, with Zhejiang Huhangyong's total assets exceeding 50% of Zhejiang Zhanyang's total assets as of the end of 2024 [27] Regulatory and Compliance Aspects - The transaction is considered a related party transaction due to both companies being controlled by the same entity, the Transportation Group [27] - The merger does not constitute a restructuring listing, as there has been no change in control within the last 36 months [27] Cash Dividend Policy - Following the merger, Zhejiang Huhangyong plans to implement a cash dividend policy, ensuring a minimum annual cash distribution of RMB 0.4100 per share for the next three years, subject to legal and regulatory compliance [28] Business Impact - The merger is expected to enhance Zhejiang Huhangyong's operational capabilities, as it combines its expressway management expertise with Zhejiang Zhanyang's focus on chemical products, including chlor-alkali products and high-purity hydrogen [28]
ST宁科: ST宁科2025年第三次临时股东会决议公告
Zheng Quan Zhi Xing· 2025-09-02 16:26
证券代码:600165 证券简称:ST 宁科 公告编号:2025-096 宁夏中科生物科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 本次股东会的召集人是公司董事会,表决方式符合《中华人民共和国公司法》 及《公司章程》的规定,会议由董事长符杰先生主持。 议案名称:关于公司新增关联关系及 2025 年度日常关联交易预计的议案 审议结果:通过 表决情况: | | | 同意 | | | 反对 | | 弃权 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 股东类型 比例 | | | | 比例 | | | 比例 | | | | 票数 | | 票数 | | | 票数 | | | | | | (%) | | (%) | | | (%) | | | A股 | 218,998,690 | 99.4761 | 1,105,500 | 0.5021 | 47,800 | 0.0218 | | | (二) | 涉及重大事项,5%以下股东的 ...
禾川科技:关于控股子公司少数股东股权转让暨关联交易的公告
Zheng Quan Ri Bao· 2025-09-02 14:09
Core Viewpoint - Hechuan Technology announced a share transfer involving its subsidiary, Zhejiang Hechuan Humanoid Robot Co., Ltd, where minority shareholder Wang Zhibin intends to transfer 13% of his 40% stake for 1.5 million yuan to Ningbo Youlong Venture Capital Partnership [2] Group 1: Share Transfer Details - Wang Zhibin holds 40% of Hechuan Robot and plans to transfer 13% of this stake [2] - The transfer price is set at 1.5 million yuan [2] - Ningbo Youlong will fulfill the corresponding capital contribution obligations for the acquired shares [2] Group 2: Regulatory and Relationship Aspects - The share transfer is classified as a related party transaction due to Ningbo Youlong being an affiliate of the company [2] - The transaction adheres to the principles outlined in the Shanghai Stock Exchange's Sci-Tech Innovation Board listing rules [2] - Post-transfer, Hechuan Technology and Ningbo Youlong will jointly hold shares in Hechuan Robot [2]
老板做多家公司影响上市,涉及三种情况
Sou Hu Cai Jing· 2025-09-02 12:08
Group 1 - The core issue affecting companies' IPOs is the presence of competing businesses controlled by the founders, which can lead to significant challenges in the listing process [1] - The case of Meiai Technology illustrates that the actual controller, Jiang Li, held 82.75% voting rights before the IPO application, which raised concerns about potential competition [2][3] - Meiai Technology's main business is air purification products, with 2021 revenue of 1.15 billion yuan and a net profit of 100 million yuan, primarily serving the semiconductor and biopharmaceutical industries [3] Group 2 - The company faced scrutiny regarding its operations in Taiwan, where it established a sales entity before privatization, generating 10 million yuan in transactions in 2020, but was restricted from including this entity in the IPO due to strict investment regulations [4] - Despite assurances that the Taiwanese entity would not operate independently, the existence of this entity led to repeated inquiries about potential competition, ultimately resulting in the decision to dissolve it to facilitate the IPO [5][6] Group 3 - The case of Changyou Technology highlights the lengthy process of resolving competition issues, taking two years to dissolve a competing entity before successfully applying for an IPO [13][14] - The company faced multiple inquiries regarding the status of the dissolved entity and its impact on the IPO process, emphasizing the importance of addressing such issues promptly [16] Group 4 - The case of Fipeng Biotechnology demonstrates the risks of delayed action in addressing competition issues, leading to a failed IPO after two and a half years of attempts [18][23] - The actual controller's involvement in multiple companies raised concerns about potential competition, requiring extensive inquiries and ultimately resulting in the withdrawal of the IPO application due to declining performance [23] Group 5 - The relationship between Meiai Technology and Tianjia Group illustrates the complexities of overlapping customer and supplier relationships, which can impact the perceived independence of a company during the IPO process [24][25] - Meiai Technology's sales to Tianjia Group amounted to 25 million yuan, representing 3% of its total sales, raising questions about the fairness of related transactions and potential conflicts of interest [27][28] Group 6 - The issue of founders holding multiple positions in different companies can also complicate the IPO process, as seen in the case of Yirui Technology, where the actual controllers were involved in several other businesses [45][60] - The potential for conflicts of interest and the need for clear separation of business operations are critical factors in ensuring a successful IPO [44][60]
药明康德: 第三届董事会第二十五次会议决议公告
Zheng Quan Zhi Xing· 2025-09-02 10:12
Group 1 - The company held its 25th meeting of the 3rd Board of Directors on September 2, 2025, with all 11 directors present, chaired by Ge Li [1] - The Board approved the proposal to cancel the Supervisory Board, change the registered capital, and amend the Articles of Association, which will take effect upon the approval of the shareholders' meeting [1][2] - The Board also approved the revision of several corporate governance systems, with unanimous support from all directors [2][3] Group 2 - The Board authorized the investment department to dispose of listed shares, with a total transaction amount not exceeding 15% of the latest audited net assets attributable to the parent company's shareholders, valid for 12 months [4][5] - The Board approved a framework agreement for daily related party transactions, with specific voting results showing 8 votes in favor and 3 abstentions from related directors [6] - The Board agreed to the equity transfer between wholly-owned subsidiaries and authorized management to handle all related matters [6][7] Group 3 - The Board proposed to hold the second extraordinary general meeting of shareholders in 2025, with the chairman or authorized personnel responsible for the announcement and related arrangements [7]
药明康德最新公告:与关联方签署框架协议暨日常关联交易的公告
Zheng Quan Zhi Xing· 2025-09-02 10:02
Core Viewpoint - WuXi AppTec (603259.SH) has signed a framework agreement with WuXi XDC Cayman Inc. to increase the transaction amount for the year 2025 and establish a new three-year service agreement [1] Group 1: Transaction Details - The expected transaction amount for 2025 has been raised from 168 million yuan to 200 million yuan [1] - Projected transaction amounts for the years 2026, 2027, and 2028 are set at 300 million yuan, 400 million yuan, and 400 million yuan respectively [1] Group 2: Related Party Transactions - The CFO of the company, Shi Ming, serves as a director of XDC Cayman, making this transaction a related party transaction [1] - The company asserts that the transaction is in line with normal business operations and is established under general business terms, adhering to market pricing principles [1]
禾川科技:控股子公司禾川机器人少数股东股权转让
Ge Long Hui· 2025-09-02 09:12
Core Points - Hechuan Technology (688320.SH) announced that its subsidiary, Zhejiang Hechuan Humanoid Robot Co., Ltd. (referred to as "Hechuan Robot"), is undergoing a share transfer involving a minority shareholder, Wang Zhibin, who holds 40% of Hechuan Robot's equity [1] - Wang Zhibin intends to transfer 13% of his equity stake (with a subscribed capital of 6.5 million yuan and a paid-in capital of 1.5 million yuan) to Ningbo Youlong Venture Capital Partnership (Limited Partnership) for a price of 1.5 million yuan [1] - Ningbo Youlong is an entity where Wang Zhibin serves as the executive partner, holding a 22.08% share of its assets, while other partners include Yan Pengfei and Xiang Yandong [1] - Yan Pengfei is currently a director and executive president of Hechuan Technology, as well as the chief technology officer of Hechuan Robot, while Xiang Yandong is the supervisor of the procurement quality department at Hechuan Robot [1] - The share transfer is classified as a related party transaction due to Ningbo Youlong being considered an affiliate of the company, following the principle of substance over form [1] - After the completion of the share transfer, Hechuan Technology will jointly hold equity in Hechuan Robot with the related party, Ningbo Youlong [1]